EUVIMEDOpdag EUVIMED
LeserbriefKommentarOpen access

COVID‐19 vaccination: Evaluation of humoral and cellular immunity after the booster dose in chronic lymphocytic leukemia patients

Giovanni Del Poeta, Roberta Laureana, Riccardo Bomben, Francesca Maria Rossi, Federico Pozzo, Eva Zaina, Ilaria Cattarossi, Paola Varaschin, Paola Nanni, Romina Boschian Boschin, Andrea Nunzi, Massimiliano Postorino and 7 more

Hematological Oncology · 2023-08 · 41 (3) · 559-562

DOI: 10.1002/hon.3121 ↗

At a glance

Leserbrief in Hematological Oncology, published online on 2023-01-09. Written by Giovanni Del Poeta and 18 co-authors. Institution: Hematology, Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy. Major MEDLINE topics: Leukemia, Lymphocytic, Chronic, B-Cell, COVID-19. Cited 2 times so far (Crossref); 11 references. The full text is freely available in PubMed Central. Funded by: Associazione Italiana Contro le Leucemie-Linfomi e Mieloma, Associazione Italiana per la Ricerca sul Cancro, Ministero della Salute.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The peer review history for this article is available at https://publons.com/publon/10.1002/hon.3121. The data that support the findings of this study are available from the corresponding author upon request. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Subjects

MeSH terms (MEDLINE)

Leukemia, Lymphocytic, Chronic, B-CellCOVID-19HumansCOVID-19 VaccinesImmunity, CellularVaccination

Substances

COVID-19 Vaccines

Authors and institutions

  • Hematology, Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
  • Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Pordenone, Italy.
  • Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Pordenone, Italy.

ORCID profiles: Antonella Zucchetto

Funding

  • Associazione Italiana Contro le Leucemie-Linfomi e Mieloma
  • Associazione Italiana per la Ricerca sul Cancro
  • Ministero della Salute

Cite

APA

Del Poeta, G., Laureana, R., Bomben, R., Rossi, F. M., Pozzo, F., Zaina, E., Cattarossi, I., Varaschin, P., Nanni, P., Boschian Boschin, R., Nunzi, A., Postorino, M., Pasqualone, G., Brisotto, G., Steffan, A., Muraro, E., Zucchetto, A., Del Principe, M. I., & Gattei, V. (2023). COVID‐19 vaccination: Evaluation of humoral and cellular immunity after the booster dose in chronic lymphocytic leukemia patients. Hematological Oncology, 41(3), 559-562. https://doi.org/10.1002/hon.3121

Vancouver

Del Poeta G, Laureana R, Bomben R, Rossi FM, Pozzo F, Zaina E, et al. COVID‐19 vaccination: Evaluation of humoral and cellular immunity after the booster dose in chronic lymphocytic leukemia patients. Hematological Oncology. 2023;41(3):559-562. doi:10.1002/hon.3121

BibTeX
@article{DelPoeta2023,
  author = {Del Poeta, Giovanni and Laureana, Roberta and Bomben, Riccardo and Rossi, Francesca Maria and Pozzo, Federico and Zaina, Eva and Cattarossi, Ilaria and Varaschin, Paola and Nanni, Paola and Boschian Boschin, Romina and Nunzi, Andrea and Postorino, Massimiliano and Pasqualone, Gianmario and Brisotto, Giulia and Steffan, Agostino and Muraro, Elena and Zucchetto, Antonella and Del Principe, Maria Ilaria and Gattei, Valter},
  title = {COVID‐19 vaccination: Evaluation of humoral and cellular immunity after the booster dose in chronic lymphocytic leukemia patients},
  journal = {Hematological Oncology},
  year = {2023},
  volume = {41},
  number = {3},
  pages = {559--562},
  doi = {10.1002/hon.3121}
}
Start for free →